FDA warns against contaminated synthetic cannabinoid products

Posted 31 July 2018

The FDA has announced that hundreds of people have been hospitalized in 10 states and several deaths have resulted from the use of unapproved, synthetic cannabinoid products that have been contaminated with brodifacoum, a long-acting anticoagulant commonly used in rat poison. Brodifacoum can cause severe bleeding. The unapproved products are being illegally marketed at convenience stores and gas stations as marijuana substitutes under names such as “K2” and “Spice.” Such products pose risks not only to individual users, but also to the U.S. blood supply if blood donors have used these products.

[Statement from FDA warning about significant health risks of contaminated illegal synthetic cannabinoid products that are being encountered by FDA. July 19, 2018]

Read the rest